Insight Wealth Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History

Insight Wealth Strategies’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.46M	Buy	8,734 +1,850	+27%	+$1.26M	0.53%	65
2026 Q1	$5.32M	Sell	6,884 -612	-8%	-$469K	0.59%	57
2025 Q4	$5.79M	Buy	7,496 +218	+3%	+$148K	0.66%	40
2025 Q3	$4.09M	Buy	+7,278	New	+$4.12M	0.48%	69
2021 Q2	–	Sell	-429	Closed	-$203K	–	226
2021 Q1	$203K	Sell	429 -6	-1%	-$2.92K	0.03%	214
2020 Q4	$210K	Buy	435 +77	+22%	+$41.6K	0.04%	215
2020 Q3	$200K	Buy	358 +34	+10%	+$20.6K	0.04%	196
2020 Q2	$202K	Buy	+324	New	+$184K	0.05%	165

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Insight Wealth Strategies's REGN Position: Q2 2026 in Review

Insight Wealth Strategies increased its Regeneron Pharmaceuticals (REGN) stake by 27% in Q2 2026, buying an estimated $1.26M and bringing the position to 8,734 shares worth $5.46M. The position accounts for 0.53% of the portfolio, ranked #65.

Insight Wealth Strategies first reported a position in REGN in Q2 2020 and has held it in 8 quarters since. The position peaked at $5.79M in Q4 2025. 374 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Insight Wealth Strategies held 8,734 shares of Regeneron Pharmaceuticals worth $5.46M as of Q2 2026.
Insight Wealth Strategies bought 1,850 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.26M.
Regeneron Pharmaceuticals made up 0.53% of Insight Wealth Strategies's portfolio in Q2 2026, its #65 holding.
Insight Wealth Strategies first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 8 quarters since.
Insight Wealth Strategies's Regeneron Pharmaceuticals position peaked at $5.79M in Q4 2025.
374 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Insight Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.